We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $116B
1-Year Est. Return 61.47%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$48.2B
AUM Growth
-$3.89B
Cap. Flow
-$1.04B
Cap. Flow %
-2.16%
Top 10 Hldgs %
23.52%
Holding
2,818
New
45
Increased
1,339
Reduced
1,028
Closed
167

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Healthcare 13.51%
3 Consumer Discretionary 13.19%
4 Financials 9.87%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCS
2501
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$110K ﹤0.01%
901
+79
+10% +$11K
LUNA
2502
DELISTED
Luna Innovations Incorporated
LUNA
$110K ﹤0.01%
14,286
+1,689
+13% +$12.1K
CSTE icon
2503
Caesarstone
CSTE
$104M
$109K ﹤0.01%
+10,356
New +$123K
KRON
2504
DELISTED
Kronos Bio
KRON
$109K ﹤0.01%
15,094
STR
2505
DELISTED
Sitio Royalties
STR
$109K ﹤0.01%
4,031
+573
+17% +$12.9K
ORMP icon
2506
Oramed Pharmaceuticals
ORMP
$178M
$108K ﹤0.01%
12,508
+1,069
+9% +$11K
LAB icon
2507
Standard BioTools
LAB
$312M
$107K ﹤0.01%
29,813
NDLS icon
2508
Noodles & Co
NDLS
$98M
$107K ﹤0.01%
2,241
+167
+8% +$10.3K
MRSN
2509
DELISTED
Mersana Therapeutics
MRSN
$105K ﹤0.01%
1,053
HFFG icon
2510
HF Foods Group
HFFG
$99.2M
$103K ﹤0.01%
15,527
CAMP
2511
DELISTED
CalAmp Corp.
CAMP
$103K ﹤0.01%
610
KOD icon
2512
Kodiak Sciences
KOD
$2.72B
$102K ﹤0.01%
13,226
-15,799
-54% -$617K
RUBY
2513
DELISTED
Rubius Therapeutics, Inc
RUBY
$100K ﹤0.01%
18,095
EPZM
2514
DELISTED
Epizyme, Inc
EPZM
$100K ﹤0.01%
87,293
+51,891
+147% +$84.6K
TK icon
2515
Teekay
TK
$1.03B
$98K ﹤0.01%
30,904
+3,676
+14% +$11.9K
VSTM icon
2516
Verastem
VSTM
$629M
$97K ﹤0.01%
5,711
-547
-9% -$9.42K
APYX icon
2517
Apyx Medical
APYX
$126M
$95K ﹤0.01%
14,510
+2,266
+19% +$22.3K
RBBN icon
2518
Ribbon Communications
RBBN
$372M
$95K ﹤0.01%
30,736
-26,897
-47% -$110K
VTGN icon
2519
VistaGen Therapeutics
VTGN
$11.6M
$93K ﹤0.01%
2,504
ABUS icon
2520
Arbutus Biopharma
ABUS
$907M
$92K ﹤0.01%
30,937
CBAY
2521
DELISTED
Cymabay Therapeutics
CBAY
$92K ﹤0.01%
29,653
AMSC icon
2522
American Superconductor
AMSC
$1.56B
$91K ﹤0.01%
11,993
+1,557
+15% +$13.3K
AKBA icon
2523
Akebia Therapeutics
AKBA
$248M
$90K ﹤0.01%
125,179
+26
+0% +$56
ACTG icon
2524
Acacia Research
ACTG
$455M
$89K ﹤0.01%
19,741
CECO icon
2525
Ceco Environmental
CECO
$4.43B
$89K ﹤0.01%
16,260
+2,041
+14% +$11.9K

Similar funds

VOYA Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, VOYA Investment Management held 2,818 positions worth $48.2B, down 7.5% from $52.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

VOYA Investment Management's Q1 2022 filing shows 45 new, 1,339 increased, 1,028 reduced and 167 closed positions. Its largest new stake was TFI International: 277,345 shares worth $29.5M. The largest sale was Marvell Technology, an estimated $487M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • VOYA Investment Management's largest Q1 2022 buy was TFI International: 277,345 shares worth $29.5M.
  • VOYA Investment Management added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $281M increase.
  • VOYA Investment Management's biggest Q1 2022 reduction was Adobe, cutting an estimated $386M.
  • VOYA Investment Management fully exited Marvell Technology in Q1 2022, selling an estimated $487M.
  • VOYA Investment Management's ten largest holdings make up 24% of its $48.2B portfolio in Q1 2022.
  • VOYA Investment Management opened 45 new positions and closed 167 in Q1 2022.
  • VOYA Investment Management's portfolio value fell 7.5% quarter-over-quarter to $48.2B.

Based on VOYA Investment Management's 13F filing for Q1 2022, filed 16 May 2022.